Delivery Order SPE2DR25D1034-SPE2DR26FPV8Q
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,096.69 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 100 tablets, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and treatment in military...
- The Defense Logistics Agency awarded a delivery order valued at $22,857.87 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The medication is an...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order valued at $10,073.70 with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,357.43 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial pharmaceutical commonly used for malaria prevention and treatment in military personnel. The contract was executed on July 14, 2025, with an ultimate completion date of July 15, 2025, and represents a firm fixed-price, non-set-aside competitive award. Performance will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.35 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract was awarded on August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial medication will support federal medical supply requirements, likely for military personnel...
- The Defense Logistics Agency awarded a delivery order valued at $2,854.36 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Atovaquone-Proguanil 250-100 mg tablets (100 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 7, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $6,044.48 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This firm fixed-price delivery order is non-set-aside and scheduled for ultimate completion by November 14, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication will support military and federal healthcare requirements through the agency's...
- The Defense Logistics Agency awarded a delivery order valued at $13,673.47 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100, a pharmaceutical product typically used for malaria prevention and treatment. The contract was awarded on September 16, 2025, with a completion date of September 17, 2025, and employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $24,468 delivery order to AmerisourceBergen Drug Corp on December 5, 2024, for the supply of Atovaquone-Proguanil 250-100 tablets in quantities of 100, with an ultimate completion date of December 6, 2024. This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count) with a firm fixed price ceiling value of $6,788.82. This contract, which is not set-aside and represents a competitive award, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The delivery order utilizes AmerisourceBergen's...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPV8QDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $38,258.58 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This competitively awarded, firm fixed-price contract with no set-aside designation was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and treatment within military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The firm is a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, with extensive experience fulfilling federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.3k | 11/13/25 |